Adverse reactions mediated by Strontium-89, Samarium-153, Rhenium-186 and Rhenium-188: A Systematic Review of Literature
C Pinho, S Martins, Â Jesus, AM Suárez - ATHENA Research Book, 2023 - recipp.ipp.pt
One of the therapies used for the palliative treatment of pain associated with bone
metastases is radiopharmaceutical therapy. Radiopharmaceuticals can cause adverse …
metastases is radiopharmaceutical therapy. Radiopharmaceuticals can cause adverse …
Adverse reactions mediated by radiopharmaceuticals for palliative treatment of bone metastases: a systematic review of literature
S Martins, CA Pinho, Â Jesus, AM Suárez - Proceedings of Research …, 2023 - parc.ipp.pt
Background: Bone metastases are one of the most frequent complications of advanced
cancers and one of the therapies used for the palliative treatment of pain associated with …
cancers and one of the therapies used for the palliative treatment of pain associated with …
Adverse reactions mediated by radiopharmaceuticals for palliative treatment of bone metastases: asystematic review of literature
C Pinho, S Martins, Â Jesus, AM Suárez - Proceedings of Research …, 2023 - recipp.ipp.pt
Bone metastases are one of the most frequent complications of advanced cancers and one
of the therapies used for the palliative treatment of pain associated with them is …
of the therapies used for the palliative treatment of pain associated with them is …
Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153
Purpose The present review article aims to provide an overview of the available
radionuclides for palliative treatment of bone metastases beyond 89 Sr and 153 Sm. In …
radionuclides for palliative treatment of bone metastases beyond 89 Sr and 153 Sm. In …
The use of radioisotopes for palliation of metastatic bone pain.
I Gkialas, L Iordanidou, I Galanakis… - Journal of BU ON …, 2008 - europepmc.org
Bone pain associated with advanced prostate and other cancers is a frequent and significant
complication. Pharmaceutical therapy of bone pain includes nonsteroidal analgesics and …
complication. Pharmaceutical therapy of bone pain includes nonsteroidal analgesics and …
Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases
Z Baranauskas, K Valuckas, E Aleknavicius… - Medicina (Kaunas …, 2006 - europepmc.org
The aim of this article was to review the available literature regarding to the use of strontium-
89 in the palliation of osteoblastic bone pain. The data of many researchers showed that …
89 in the palliation of osteoblastic bone pain. The data of many researchers showed that …
Radiopharmaceuticals for the palliation of painful bone metastases—a systematic review
G Bauman, M Charette, R Reid, J Sathya… - Radiotherapy and …, 2005 - Elsevier
BACKGROUND AND PURPOSE: The purpose was to develop a systematic review that
would address the following question: what is the role of radiopharmaceuticals in the …
would address the following question: what is the role of radiopharmaceuticals in the …
Effectiveness of radioisotope therapy in bone metastases, based on personal experience
T Skóra, T Kowalska, K Zawiła - Contemporary Oncology/Współczesna …, 2012 - termedia.pl
Effectiveness of radioisotope therapy in bone metastases, based on personal experience
Journals Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …
Journals Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii …
Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases
K Liepe, W G-Franke, J Kropp, R Koch… - Nuklearmedizin …, 2000 - thieme-connect.com
Aim: Several radiopharmaceuticals were compared previously with regard to the efficiency
in pain palliation of bone metastases. Furthermore, first results were reported on the …
in pain palliation of bone metastases. Furthermore, first results were reported on the …
Strontium-89 in palliative treatement of painfull bone metastases.
P Zorga, B Birkenfeld - Ortopedia, Traumatologia, Rehabilitacja, 2003 - europepmc.org
Background. Bone metastases are observed in 30-70% of patients with cancer. Pain is most
frequent symptom that requires regular control and treatment. Systemic palliative …
frequent symptom that requires regular control and treatment. Systemic palliative …